Is Neisseria (N.) meningitidis susceptible to doxycycline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Susceptibility of Neisseria meningitidis to Doxycycline

Yes, Neisseria meningitidis is generally susceptible to doxycycline, which can be used as an effective antibiotic for prophylaxis in close contacts of meningococcal disease patients. 1, 2

Evidence of Susceptibility

  • Doxycycline has demonstrated effectiveness against N. meningitidis and is included in treatment regimens for close contacts of meningococcal disease patients 3
  • Studies examining the susceptibility of N. meningitidis to various antimicrobial agents have shown that tetracyclines, including doxycycline, are effective against most meningococcal strains 2
  • Historical data indicates that tetracycline has shown 100% effectiveness against N. meningitidis isolates in susceptibility testing 4

Clinical Applications

Prophylaxis for Close Contacts

  • Doxycycline is one of several antibiotics that can be used in combination regimens for prophylaxis of close contacts of meningococcal disease patients 1, 3
  • When ciprofloxacin resistance is present in a local area, doxycycline is among the alternative recommended antibiotics for prophylaxis, along with rifampin, ceftriaxone, and azithromycin 3
  • Doxycycline has been used in combination with ceftriaxone for treating pharyngeal N. gonorrhoeae infections, suggesting similar effectiveness against the related Neisseria species N. meningitidis 1

Treatment Considerations

  • While N. meningitidis is generally susceptible to doxycycline, it is not typically used as first-line therapy for invasive meningococcal disease 1
  • For invasive meningococcal infections including meningitis, cephalosporins (particularly ceftriaxone) are preferred due to their excellent CSF penetration and established efficacy 5
  • Penicillin remains effective against most N. meningitidis strains, with reduced susceptibility occurring in only about 16% of community-acquired cases 1

Resistance Concerns

  • Some N. meningitidis strains may exhibit elevated tetracycline and doxycycline MICs due to efflux-mediated resistance encoded by tet(B), though this appears to be relatively uncommon 2
  • Minocycline (another tetracycline) may retain activity against some strains with resistance to other tetracyclines 2
  • Ongoing surveillance for antibiotic resistance is essential, as resistance patterns can change over time 3

Clinical Recommendations

  • For prophylaxis of close contacts of meningococcal disease patients, doxycycline can be considered as an alternative when ciprofloxacin resistance is present 3
  • For treatment of invasive meningococcal disease, including meningitis, cephalosporins like ceftriaxone remain the preferred agents 5
  • When treating suspected meningococcal infections in areas with known resistance patterns, antimicrobial selection should be guided by local susceptibility data 1
  • In cases of confirmed meningococcal meningitis, doxycycline should not be used as monotherapy due to the availability of more established treatment options with better CNS penetration 1, 5

Important Caveats

  • Susceptibility testing of meningococcal isolates should be performed whenever possible to guide therapy, especially in areas with emerging resistance 1
  • Resistance patterns can vary geographically and change over time, necessitating ongoing surveillance 3, 2
  • While doxycycline is generally effective against N. meningitidis, its use in clinical practice is primarily for prophylaxis rather than treatment of invasive disease 3, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.